A PIPELINE POWERED BYPASSION
PUBLICATIONS AND PRESENTATIONS
Relative Bioavailability of Omecamtiv Mecarbil Pediatric Minitablet Formulations in Healthy Adult Subjects
Clinical Drug Investigation
Trivedi A, Mackowski M, Jafarinasabian P, Zhang H, Flach S, Terminello B, Bhatia A, Dutta S, Lee E
June 10, 2021
Effect of Varying Degrees of Hepatic Impairment on the Pharmacokinetics of Omecamtiv Mecarbil
Clinical Pharmacology in Drug Development
Trivedi A, Oberoi RK, Mackowski M, Jafarinasabian P, Zhang H, Flach S, Hutton S, Abbasi S, Dutta S, Lee E
June 9, 2021
Effect of Omecamtiv Mecarbil on the Pharmacokinetics of Metformin, a Probe Substrate for MATE1/MATE2-K, in Healthy Subjects
Clinical Drug Investigation
Trivedi A, Oberoi RK, Jafarinasabian P, Zhang H, Spring M, Flach S, Abbasi S, Dutta S, Lee E
June 7, 2021
Switchability and minimal effect of food on pharmacokinetics of modified release tablet strengths of omecamtiv mecarbil, a cardiac myosin activator
Biopharmaceutics & Drug Disposition
Trivedi A, Oberoi RK, Mackowski M, Jafarinasabian P, Zhang H, Flach S, Simiens M, Terminello B, Abbasi S, Dutta S, Lee E
June 4, 2021
Impact of Ejection Fraction on the Therapeutic Effect of Omecamtiv Mecarbil in Patients with Reduced Ejection Fraction: A Secondary Analysis from GALACTIC-HF
Presentation, American College of Cardiology 70th Annual Scientific Session & Expo (ACC.21)
Teerlink JR
Virtual
May 17, 2021